Prostate-Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography: A Meta-Analysis for This Diagnostic Triad of Prostate Cancer in Symptomatic Korean Men

We conducted a meta-analysis using results from the Korean literature to determine whether prostate-specific antigen (PSA) or digital rectal examination (DRE) or transrectal ultrasonography (TRUS) provides a better diagnostic outcome for possible prostate cancer patients. An extensive literature search of MedRIC database et al. (1980 to 2003) was performed using the medical subject headings "PSA", "DRE", "TRUS" and "prostate cancer". Of the 108 articles that we retrieved, 13 studies (2,029 subjects) were selected for this meta-analysis. The criteria for quality evaluation were as follows: the study subjects must have been compared clinically for suspected prostate cancer, and the articles must have included individual data about sensitivity and specificity for this diagnostic triad based on the biopsy results as a reference standard. For the quantitative meta-analysis process the Hasselblad method was utilized. The pooled sensitivity and specificity for a PSA level greater than 4 ng/mL were 91.3% and 35.9%, respectively; and those for a PSA level greater than 10 ng/mL were 77.3% and 67.5%, respectively; and those for DRE were 68.4% and 71.5%, respectively; and those for TRUS were 73.6% and 61.3%, respectively. According to the results in a fixed effect model for PSA criteria, the estimates of d for PSA4 and PSA10 were 0.8517 [95% confidence interval (CI): 0.6694, 1.0340] and 1.0996 (95% CI: 0.9459, 1.2534), respectively. Also, according to the results using a random effect model for both DRE and TRUS criteria, the estimates of d for DRE and TRUS were 0.8398 (95% CI: 0.7169, 0.9627) and 0.8002 (95% CI: 0.6714, 0.9289), respectively. The detection rate for combination testing of PSA, DRE and TRUS for the diagnosis of prostate cancer jumped further to 68.3% or to 76.8%. In conclusion, this study suggests that this diagnostic triad for prostate cancer was noneffective when they were used separately. Therefore, we recommend that the urologists should use PSA together with DRE and TRUS for the primary diagnosis of prostate cancer in men with lower urological symptoms.

[1]  Ian M Thompson,et al.  Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker , 2004, Cancer.

[2]  S. Naylor,et al.  Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis , 2004, Disease markers.

[3]  A. Berg.  Screening for prostate cancer: recommendations and rationale. , 2003, The American journal of nursing.

[4]  V. Kataja,et al.  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Yingdong Zhao,et al.  Molecular Differentiation of High- and Moderate-Grade Human Prostate Cancer by cDNA Microarray Analysis , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[6]  G. Cable,et al.  Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. , 2003, The Journal of the American Board of Family Practice.

[7]  U. P. S. T. Force,et al.  Screening for prostate cancer: recommendations and rationale. , 2003, American family physician.

[8]  U. P. S. T. Force,et al.  Screening for Prostate Cancer: Recommendation and Rationale , 2002, Annals of Internal Medicine.

[9]  O John Semmes,et al.  Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Choung-Soo Kim,et al.  Survey of incidence of urological cancer in South Korea: A 15‐year summary , 2002, International journal of urology : official journal of the Japanese Urological Association.

[11]  Patrick M M Bossuyt,et al.  Exploring sources of heterogeneity in systematic reviews of diagnostic tests , 2002, Statistics in medicine.

[12]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[13]  Chun-Bae Kim.  Clinical Practice Guidelines in Korea: Development and Implementation , 2001 .

[14]  H. Colstrup,et al.  [Transrectal ultrasonography of the prostate]. , 2001, Ugeskrift for laeger.

[15]  B. Littenberg,et al.  Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels , 2000, Journal of General Internal Medicine.

[16]  F. Buntinx,et al.  The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. , 1999, Family practice.

[17]  L. Kolonel,et al.  Dietary fat and prostate cancer: current status. , 1999, Journal of the National Cancer Institute.

[18]  Bohyun Kim,et al.  Usefulness of Transrectal Ultrasound in Diagnosing Prostate Cancer: Comparison with Digital RectalExamination, Prostate-Specific Antigen and Prostate-Specific Antigen Density , 1998 .

[19]  S. Woolf,et al.  American College of Preventive Medicine Practice Policy Screening for Prostate Cancer in American Men , 1998 .

[20]  J. Paick,et al.  The Value of Prostate Specific Antigen Density in the Diagnosis of Prostate Adenocarcinoma , 1998 .

[21]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[22]  Choal Hee Park,et al.  Prostate Cancer Detection in Clinical Urologic Practice : Comparison of Digital Rectal Examination, Serum PSA Level, and Transrectal Ultrasonography , 1996 .

[23]  S. Park,et al.  Early Experience of Transperineal Prostatic Biopsy under Transrectal Ultrasound Guidance , 1995 .

[24]  A. Whittemore,et al.  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. , 1995, Journal of the National Cancer Institute.

[25]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[26]  V Hasselblad,et al.  Meta-analytic Tools for Medical Decision Making: A Practical Guide , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[27]  K. King,et al.  Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: How effective is this diagnostic triad? , 1994, Journal of surgical oncology.

[28]  P. Walsh.  Disease-specific survival following routine prostate cancer screening by digital rectal examination. , 1993, The Journal of urology.

[29]  L E Moses,et al.  Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. , 1993, Statistics in medicine.

[30]  Jenny Donovan,et al.  Screening for prostate cancer , 1993, JAMA.

[31]  C. Mettlin,et al.  Trends in prostate cancer care in the United States, 1974–1990: Observations from the patient care evaluation studies of the American college of surgeons commission on cancer , 1993, CA: a cancer journal for clinicians.

[32]  J. Knottnerus,et al.  The diagnostic value of rectal examination. , 1993, Family practice.

[33]  B. McNeil,et al.  Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer. Results of a Multi-Institutional Cooperative Trial , 1991, Investigative Radiology.

[34]  G. Murphy,et al.  Transrectal ultrasonography of the prostate , 1984, Cancer.

[35]  S. Kwon,et al.  Suprapubic Ultrasonographic Findings of the Prostatic Diseases , 1982 .

[36]  G. Murphy,et al.  Purification of a human prostate specific antigen. , 1979, Investigative urology.

[37]  Y. Tanahashi,et al.  Transrectal ultrasonotomography of the prostate. , 1975, The Journal of urology.

[38]  W. A. Soanes,et al.  Tissue- and species-specific antigens of normal human prostatic tissue. , 1970, Journal of immunology.

[39]  P. Bunting,et al.  Screening for prostate cancer with prostate-specific antigen: beware the biases. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[40]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[41]  K. S. Lee,et al.  Diagnostic Value for Early Detection of Prostate Cancer of the Digital Rectal Examination, Serum Prostate Antigen and Transrectal Ultrasonography. , 1999 .

[42]  P Glasziou,et al.  Meta-analytic methods for diagnostic test accuracy. , 1995, Journal of clinical epidemiology.

[43]  L. Hedges,et al.  Meta-analysis of screening and diagnostic tests. , 1995, Psychological bulletin.

[44]  D. C. Aziz,et al.  Prostate‐specific antigen and prostate volume: A meta‐analysis of prostate cancer screening criteria , 1993, Journal of clinical laboratory analysis.